Skip to main navigation
en
  • Support
    • Contact Us
      Contact Us
    • FAQ
      FAQ
  • My Orders
    • Open Orders
    • Drafts
    • Past Orders
  • Sign In
logo (slate) Created with Sketch. logo Created with Sketch.
  • Products
    • Genes Genes
    • Oligo Pools Oligo Pools
    • NGS NGS
    • Variant Libraries Variant Libraries
    • Synthetic Controls Synthetic Controls
    • Antibodies Antibodies
    • SARS-CoV-2 Tools SARS-CoV-2 Tools
    • DNA Data Storage DNA Data Storage

    Genes Genes

    Order Now
    • Clonal Genes
    • Gene Fragments
    Learn how to accelerate your research with Twist Genes

    Learn how to accelerate your research with Twist Genes

    NGS NGS Target Enrichment Solutions

    Order Now
    • Custom Panels
    • Alliance PanelsNew
    • Library Preparation
      • Enzymatic Fragmentation KitNew
      • Universal Adapter System
      • UMI Adapter SystemNew
      • Twist 96-Plex Library Prep KitNew
    • Reagents & Kits
      • Fast Hybridization and Wash Kit
      • Standard Hybridization and Wash Kit
      • Universal Blockers
      • Methylation Detection SystemNew
    • Controls and Standards
      • SARS-CoV-2 RNA Controls
      • Respiratory Virus Controls
      • cfDNA Pan-cancer Reference Standards
    • Fixed Panels
      • Exome 2.0New
      • Human Comprehensive Exome
      • Human Core Exome
      • Human RefSeq Panel
      • Mitochondrial Panel
      • Mouse Exome Panel
      • Respiratory Virus Research Panel
      • SARS-CoV-2 Research Panel
      • SARS-CoV-2 NGS Assay-EUA
      • Comprehensive Viral Research Panel
    Learn more about the new standard for Exome sequencing

    Learn more about the new standard for Exome sequencing

    Variant Libraries Variant Libraries

    Order Now
    • Combinatorial Variant Library
    • Spread Out Low Diversity Libraries
    • Site Saturation Libraries
    Watch how Twist builds variant libraries for your perfect application

    Watch how Twist builds variant libraries for your perfect application

    Synthetic Controls Synthetic Controls

    • Liquid Biopsy
      • cfDNA Pan-cancer Reference Standards
    • Infectious Disease
      • SARS-CoV-2 Controls
      • Respiratory Virus Controls
    Check out our new synthetic controls for liquid biopsy assay development

    Check out our new synthetic controls for liquid biopsy assay development

    Antibodies Antibodies

    Order Now
    • High Throughput Antibody ProductionNew
    • ANTIBODIES SERVICES
      • Antibody Discovery
      • Antibody Optimization
      • Partnership & Collaborations
      • Pipeline & Licensing
    • Catalog Antibodies
      • Anti-ACE2
      • Anti-SARS-CoV-2 S1
    Read our new Ebook on antibody discovery and development

    Read our new Ebook on antibody discovery and development

    SARS-CoV-2 Tools Tools for SARS-COV-2

    Order Now
    • SARS-CoV-2 NGS Assay-EUA
    • Synthetic Controls
      • SARS-CoV-2 RNA Controls
      • Respiratory Virus Controls
    • Fixed Panels
      • SARS-CoV-2 Research Panel
    • Catalog Antibodies
      • Anti-ACE2
      • Anti-SARS-CoV-2 S1
    Check out our tools for coronavirus detection and surveillance research

    Check out our tools for coronavirus detection and surveillance research

  • Services
    • Biopharma
    • Twist API
    • Procurement Integrations
    • Antibodies Services
      • Antibody Discovery
      • Antibody Optimization
      • Pipeline & Licensing
      • Partnership & Collaborations
  • Resources
    • Technical Resources
    • Webinars
    • Case Studies
    • Publications
    • Blog
    • FAQ
  • Company
    • Company
    • Technology
    • Investor Relations
    • Partnerships
    • About
    • Team
    • Careers
    • Investor Relations
    • Events
    • Contact
    • Blog
    • ESG
    • Overview
    • Ordering Platform
    • Twist API

    Overview

    • Stock
      • Stock Quote Chart
      • Analyst Coverage
    • News and Events
      • Press Releases
      • Investor Calendar
      • Presentations
    • Financials
      • Sec Filings
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Email Alerts
      • IR Contacts
    • NGS ProLab
    • Channel Partners and Distributors
  • Start Order
    • Synthetic Controls
      Synthetic Controls
    • Genes
      Genes
    • Oligo Pools
      Oligo Pools
    • Custom Vectors
      Custom Vectors
    • Antibodies
      Antibodies
    • Get Quote

      Libraries
      Libraries
    • NGS
      NGS
HOME
close menu
Language
    Products
    close menu
    • Oligo Pools
    • DNA Data Storage
    Services
    close menu
    • Twist API
    • Procurement Integrations
    Resources
    close menu
    • Technical Resources
    • Webinars
    • Case Studies
    • Publications
    • Blog
    • FAQ
    Company
    close menu
    Support
    close menu
    • Contact Us
    • FAQ
    Genes
    close menu
    • Overview
    • Clonal Genes
    • Gene Fragments
    NGS Target Enrichment Solutions
    close menu
    • Overview
    • Custom Panels
    • Alliance PanelsNew
    • Library Preparation
      • Enzymatic Fragmentation KitNew
      • Universal Adapter System
      • UMI Adapter SystemNew
      • Twist 96-Plex Library Prep KitNew
    • Reagents & Kits
      • Fast Hybridization and Wash Kit
      • Standard Hybridization and Wash Kit
      • Universal Blockers
      • Methylation Detection SystemNew
    • Controls and Standards
      • SARS-CoV-2 RNA Controls
      • Respiratory Virus Controls
      • cfDNA Pan-cancer Reference Standards
    • Fixed Panels
      • Exome 2.0New
      • Human Comprehensive Exome
      • Human Core Exome
      • Human RefSeq Panel
      • Mitochondrial Panel
      • Mouse Exome Panel
      • Respiratory Virus Research Panel
      • SARS-CoV-2 Research Panel
      • SARS-CoV-2 NGS Assay-EUA
      • Comprehensive Viral Research Panel
    Variant Libraries
    close menu
    • Overview
    • Combinatorial Variant Library
    • Spread Out Low Diversity Libraries
    • Site Saturation Libraries
    Synthetic Controls
    close menu
    • Overview
    • Liquid Biopsy
      • cfDNA Pan-cancer Reference Standards
    • Infectious Disease
      • SARS-CoV-2 Controls
      • Respiratory Virus Controls
    Antibodies
    close menu
    • Overview
    • High Throughput Antibody ProductionNew
    • ANTIBODIES SERVICES
      • Antibody Discovery
      • Antibody Optimization
      • Partnership & Collaborations
      • Pipeline & Licensing
    • Catalog Antibodies
      • Anti-ACE2
      • Anti-SARS-CoV-2 S1
    Tools for SARS-COV-2
    close menu
    • Overview
    • SARS-CoV-2 NGS Assay-EUA
    • Synthetic Controls
      • SARS-CoV-2 RNA Controls
      • Respiratory Virus Controls
    • Fixed Panels
      • SARS-CoV-2 Research Panel
    • Catalog Antibodies
      • Anti-ACE2
      • Anti-SARS-CoV-2 S1
    Biopharma
    close menu
    • Overview
    • Antibodies Services
      • Antibody Discovery
      • Antibody Optimization
      • Pipeline & Licensing
      • Partnership & Collaborations
    Company
    close menu
    • Overview
    • About
    • Team
    • Careers
    • Investor Relations
    • Events
    • Contact
    • Blog
    • ESG
    Technology
    close menu
    • Overview
    • Overview
    • Ordering Platform
    • Twist API
    Overview
    close menu
    • Overview
    • Stock
      • Stock Quote Chart
      • Analyst Coverage
    • News and Events
      • Press Releases
      • Investor Calendar
      • Presentations
    • Financials
      • Sec Filings
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Email Alerts
      • IR Contacts
    Partnerships
    close menu
    • Overview
    • NGS ProLab
    • Channel Partners and Distributors
    IR banner image 
    print-logo

    Investor Relations

    Investors
    • Overview
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Investor Calendar
      • Presentations
    • Financials
      • SEC Filings
      • Annual Reports
    • Governance
      • Governance Highlights
      • Committee Composition
    • Resources
      • Email Alerts
      • IR Contacts

    SEC Filing Details

    Document Details

    Form
    4
    Filing Date
    Feb 22, 2023
    Document Date
    Feb 17, 2023
    Form Description
    Statement of changes in beneficial ownership of securities
    Filing Group
    3,4,5
    Company
    Twist Bioscience
    Issuer
    Twist Bioscience Corp
    Filer
    Banyai William

    Filing Formats

    View HTML
    Download PDF
    Download DOC
    Download XLS
    • Print Page
    • Email Page
    • Email Alerts
    • RSS Feeds
    Quick Links

    Integrations

    • Integrations
      • TAPI
      • Procurement Integrations
    • Technology
      • Overview
      • Ordering Platform

    Resources

    • Resources
      • Technical Resources
      • Webinars
      • Case Studies
      • Publications
      • Blog

    Partnerships

    • Partnerships
      • NGS Prolab
      • Channel Partners & Distributors

    Company

    • Company
      • About
      • Team
      • Careers
      • Investor Relations
      • Events
      • Biopharma
    Twist Bioscience Logo
    Twist Bioscience HQ
    681 Gateway Blvd
    South San Francisco, CA 94080

    Footer

    • Latest
      • Contact Us
      • FAQ
    • Get In Touch
      • Twitter
      • Facebook
      • LinkedIn
      • YouTube
      • icp
        • 粤ICP备2020105487号

    Bottom Links

    • Twist QMS & Quality Policy
    • Privacy Policy
    • Terms & Conditions
    • Supply Terms and Conditions
    • Policy on Unsolicited Submissions of Information
    • Regulatory and Quality Information
    • Security
    • © 2023 Twist Bioscience. All rights reserved.